Parkinson's - McKnight's Senior Living


Pfizer to end Alzheimer’s, Parkinson’s research

Pharmaceutical company Pfizer has announced that it will end its research and development programs for Alzheimer’s and Parkinson’s treatments and “re-allocate funding to those areas where we have strong scientific leadership and that will allow us to provide the greatest impact for patients.”

More news for Monday, Sept. 18

American Senior Communities takes former CEO, execs to court … Couple racks up 27 counts after alleged thefts at senior living community … Medical history can point to earlier Parkinson’s diagnosis

Next post in News